Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.

Detalles Bibliográficos
Autores principales: Jung, Minkyu, Kim, Se Hyun, Hong, Soojung, Kang, Young Ae, Kim, Se Kyu, Chang, Joon, Rha, Sun Young, Kim, Joo Hang, Kim, Dae Joon, Cho, Byoung Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2013
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521263/
https://www.ncbi.nlm.nih.gov/pubmed/23225832
http://dx.doi.org/10.3349/ymj.2013.54.1.269
_version_ 1782252917517975552
author Jung, Minkyu
Kim, Se Hyun
Hong, Soojung
Kang, Young Ae
Kim, Se Kyu
Chang, Joon
Rha, Sun Young
Kim, Joo Hang
Kim, Dae Joon
Cho, Byoung Chul
author_facet Jung, Minkyu
Kim, Se Hyun
Hong, Soojung
Kang, Young Ae
Kim, Se Kyu
Chang, Joon
Rha, Sun Young
Kim, Joo Hang
Kim, Dae Joon
Cho, Byoung Chul
author_sort Jung, Minkyu
collection PubMed
description
format Online
Article
Text
id pubmed-3521263
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Yonsei University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-35212632013-01-01 Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9. Jung, Minkyu Kim, Se Hyun Hong, Soojung Kang, Young Ae Kim, Se Kyu Chang, Joon Rha, Sun Young Kim, Joo Hang Kim, Dae Joon Cho, Byoung Chul Yonsei Med J Retraction Yonsei University College of Medicine 2013-01-01 2012-11-28 /pmc/articles/PMC3521263/ /pubmed/23225832 http://dx.doi.org/10.3349/ymj.2013.54.1.269 Text en © Copyright: Yonsei University College of Medicine 2013 http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Jung, Minkyu
Kim, Se Hyun
Hong, Soojung
Kang, Young Ae
Kim, Se Kyu
Chang, Joon
Rha, Sun Young
Kim, Joo Hang
Kim, Dae Joon
Cho, Byoung Chul
Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title_full Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title_fullStr Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title_full_unstemmed Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title_short Retraction: Prognostic and Predictive Value of Carcinoembryonic Antigen and Cytokeratin-19 Fragments Levels in Advanced Non-Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib. Yonsei Med J 2012;53:931-9.
title_sort retraction: prognostic and predictive value of carcinoembryonic antigen and cytokeratin-19 fragments levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib. yonsei med j 2012;53:931-9.
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521263/
https://www.ncbi.nlm.nih.gov/pubmed/23225832
http://dx.doi.org/10.3349/ymj.2013.54.1.269
work_keys_str_mv AT jungminkyu retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT kimsehyun retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT hongsoojung retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT kangyoungae retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT kimsekyu retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT changjoon retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT rhasunyoung retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT kimjoohang retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT kimdaejoon retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319
AT chobyoungchul retractionprognosticandpredictivevalueofcarcinoembryonicantigenandcytokeratin19fragmentslevelsinadvancednonsmallcelllungcancerpatientstreatedwithgefitiniborerlotinibyonseimedj2012539319

Ejemplares similares